Vyndamax 61 MG capsule UD 30S
Ended Awarded
- Contract number
- SPE2DB25FDAWQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,847
Award facts
- Contract value 100% obligated
- $13,846.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for VYNDAMAX 61 mg capsules (30-count unit dose packaging) on September 25, 2025, with an ultimate completion date of October 17, 2025. This firm fixed-price, non-set-aside award is being performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle valued through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant position within the federal medical supply chain and has been competitively awarded multiple contracts by the DLA for various pharmaceutical products and medical supplies supporting military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. VYNDAMAX (venyldopa) is a neurological treatment medication, consistent with AmerisourceBergen's established role in supplying specialized pharmaceutical products to support Defense Health Agency and other federal healthcare system requirements.
Quick answers
Who was awarded contract SPE2DB25FDAWQ?
SPE2DB25FDAWQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FDAWQ worth?
The government has obligated $13,847 on SPE2DB25FDAWQ.
Is contract SPE2DB25FDAWQ an order under another contract?
Yes. SPE2DB25FDAWQ is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FDAWQ competed?
The extent of competition for SPE2DB25FDAWQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award